SULT2A1 and adrenal cortex carcinoma: Some ACC patients showed increased levels of steroid markers (including androstenedione, DHEAS, 11-deoxycortisol, progesterone, 17-hydroxypregnenolone, 17-hydroxyprogesterone [17OHP], and 11-deoxycorticosterone), whereas others did not demonstrate this trend.